Market Closed -
Hong Kong S.E.
04:09:05 2024-06-07 am EDT
|
5-day change
|
1st Jan Change
|
22.55
HKD
|
+2.04%
|
|
+7.38%
|
+10.27%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
75,452
|
49,504
|
43,125
|
54,681
|
58,004
|
63,973
|
-
|
-
|
Enterprise Value (EV)
1 |
91,399
|
63,204
|
63,166
|
64,207
|
71,347
|
74,013
|
69,696
|
71,858
|
P/E ratio
|
12.1
x
|
6.87
x
|
5.55
x
|
6.42
x
|
6.41
x
|
6.61
x
|
6.02
x
|
5.5
x
|
Yield
|
2.36%
|
4.35%
|
5.43%
|
4.68%
|
4.68%
|
4.58%
|
5.03%
|
5.42%
|
Capitalization / Revenue
|
0.18
x
|
0.11
x
|
0.08
x
|
0.1
x
|
0.1
x
|
0.1
x
|
0.09
x
|
0.08
x
|
EV / Revenue
|
0.21
x
|
0.14
x
|
0.12
x
|
0.12
x
|
0.12
x
|
0.11
x
|
0.1
x
|
0.09
x
|
EV / EBITDA
|
5.09
x
|
3.21
x
|
2.67
x
|
2.59
x
|
2.9
x
|
2.83
x
|
2.44
x
|
2.32
x
|
EV / FCF
|
6.57
x
|
-13.8
x
|
9.72
x
|
3.47
x
|
4.86
x
|
15.5
x
|
7.37
x
|
7.68
x
|
FCF Yield
|
15.2%
|
-7.24%
|
10.3%
|
28.8%
|
20.6%
|
6.45%
|
13.6%
|
13%
|
Price to Book
|
1.59
x
|
0.88
x
|
0.7
x
|
0.8
x
|
0.78
x
|
0.77
x
|
0.69
x
|
0.62
x
|
Nbr of stocks (in thousands)
|
2,967,629
|
3,118,654
|
3,120,656
|
3,120,656
|
3,120,656
|
3,120,656
|
-
|
-
|
Reference price
2 |
25.42
|
15.87
|
13.82
|
17.52
|
18.59
|
20.50
|
20.50
|
20.50
|
Announcement Date
|
3/30/20
|
3/21/21
|
3/20/22
|
3/26/23
|
3/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
425,273
|
456,415
|
521,051
|
552,148
|
596,570
|
646,953
|
704,115
|
766,912
|
EBITDA
1 |
17,950
|
19,667
|
23,634
|
24,769
|
24,639
|
26,172
|
28,563
|
30,977
|
EBIT
1 |
16,137
|
17,760
|
19,712
|
20,604
|
20,209
|
23,064
|
25,176
|
27,451
|
Operating Margin
|
3.79%
|
3.89%
|
3.78%
|
3.73%
|
3.39%
|
3.57%
|
3.58%
|
3.58%
|
Earnings before Tax (EBT)
1 |
13,760
|
15,598
|
17,003
|
18,564
|
19,512
|
20,858
|
22,958
|
25,119
|
Net income
1 |
6,253
|
7,187
|
7,759
|
8,526
|
9,054
|
9,671
|
10,627
|
11,637
|
Net margin
|
1.47%
|
1.57%
|
1.49%
|
1.54%
|
1.52%
|
1.49%
|
1.51%
|
1.52%
|
EPS
2 |
2.100
|
2.310
|
2.490
|
2.730
|
2.900
|
3.102
|
3.407
|
3.727
|
Free Cash Flow
1 |
13,909
|
-4,574
|
6,501
|
18,481
|
14,685
|
4,771
|
9,453
|
9,355
|
FCF margin
|
3.27%
|
-1%
|
1.25%
|
3.35%
|
2.46%
|
0.74%
|
1.34%
|
1.22%
|
FCF Conversion (EBITDA)
|
77.49%
|
-
|
27.51%
|
74.61%
|
59.6%
|
18.23%
|
33.09%
|
30.2%
|
FCF Conversion (Net income)
|
222.46%
|
-
|
83.79%
|
216.77%
|
162.19%
|
49.34%
|
88.95%
|
80.39%
|
Dividend per Share
2 |
0.6000
|
0.6900
|
0.7500
|
0.8200
|
0.8700
|
0.9393
|
1.031
|
1.112
|
Announcement Date
|
3/30/20
|
3/21/21
|
3/20/22
|
3/26/23
|
3/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
223,608
|
203,765
|
252,650
|
249,120
|
271,931
|
261,472
|
290,676
|
18,687
|
155,433
|
300,950
|
144,969
|
150,650
|
295,619
|
311,580
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
8,772
|
10,940
|
9,057
|
11,547
|
-
|
5,895
|
10,869
|
5,937
|
4,691
|
10,628
|
10,518
|
Operating Margin
|
-
|
-
|
-
|
3.52%
|
4.02%
|
3.46%
|
3.97%
|
-
|
3.79%
|
3.61%
|
4.1%
|
3.11%
|
3.6%
|
3.38%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
5,228
|
8,866
|
4,161
|
6,485
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
362.2
|
2,514
|
4,104
|
1,752
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.94%
|
1.62%
|
1.36%
|
1.21%
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/20
|
8/23/20
|
3/21/21
|
8/22/21
|
3/20/22
|
8/29/22
|
3/26/23
|
4/17/23
|
8/27/23
|
8/27/23
|
10/30/23
|
3/24/24
|
3/24/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,947
|
13,699
|
20,041
|
9,526
|
13,343
|
10,040
|
5,723
|
7,885
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.8884
x
|
0.6966
x
|
0.848
x
|
0.3846
x
|
0.5415
x
|
0.3836
x
|
0.2004
x
|
0.2545
x
|
Free Cash Flow
1 |
13,909
|
-4,574
|
6,501
|
18,481
|
14,685
|
4,771
|
9,453
|
9,355
|
ROE (net income / shareholders' equity)
|
13.9%
|
13.9%
|
13.1%
|
13.1%
|
12.7%
|
11.9%
|
11.9%
|
11.7%
|
ROA (Net income/ Total Assets)
|
2.47%
|
2.47%
|
2.4%
|
2.44%
|
2.42%
|
2.38%
|
2.42%
|
2.41%
|
Assets
1 |
252,832
|
290,559
|
323,331
|
350,101
|
374,091
|
406,829
|
439,927
|
483,178
|
Book Value Per Share
2 |
16.00
|
18.10
|
19.80
|
21.80
|
23.90
|
26.70
|
29.80
|
32.90
|
Cash Flow per Share
2 |
6.320
|
3.590
|
2.980
|
6.720
|
5.500
|
6.040
|
3.430
|
6.080
|
Capex
1 |
4,868
|
4,585
|
2,807
|
2,482
|
2,488
|
3,058
|
2,902
|
3,042
|
Capex / Sales
|
1.14%
|
1%
|
0.54%
|
0.45%
|
0.42%
|
0.47%
|
0.41%
|
0.4%
|
Announcement Date
|
3/30/20
|
3/21/21
|
3/20/22
|
3/26/23
|
3/24/24
|
-
|
-
|
-
|
Last Close Price
20.5
CNY Average target price
24.68
CNY Spread / Average Target +20.40% Consensus |
1st Jan change
|
Capi.
|
---|
| +10.27% | 8.83B | | +26.60% | 76.19B | | -1.98% | 24.06B | | +10.22% | 8.51B | | -22.96% | 7.72B | | +12.39% | 5.2B | | +3.16% | 4.18B | | -5.61% | 4.01B | | +4.85% | 3.86B | | +0.94% | 3.09B |
Pharmaceuticals Wholesale
|